THP-1 Cell Apoptosis in Response to Mycobacterial Infection
Overview
Authors
Affiliations
We previously reported that Mycobacterium tuberculosis infection primes human alveolar macrophages (HAM) for tumor necrosis factor alpha (TNF-alpha)-mediated apoptosis and that macrophage apoptosis is associated with killing internalized bacilli. Virulent mycobacterial strains elicit much less apoptosis than attenuated strains, implying that apoptosis is a defense against intracellular infection. The present study evaluated the potential for phorbol myristate acetate-differentiated THP-1 cells to mimic this response of primary macrophages. Consistent with the behavior of alveolar macrophages, attenuated M. tuberculosis H37Ra and Mycobacterium bovis BCG strongly induce THP-1 apoptosis, which requires endogenous TNF. THP-1 apoptosis is associated with reduced viability of infecting BCG. In contrast, virulent wild-type M. tuberculosis H37Rv and M. bovis do not increase THP-1 apoptosis over baseline. BCG induced early activation of caspase 10 and 9, followed by caspase 3. In contrast, wild-type M. bovis infection failed to activate any caspases in THP-1 cells. BCG-induced THP-1 apoptosis is blocked by retroviral transduction with vectors expressing crmA but not bcl-2. We conclude that differentiated THP-1 cells faithfully model the apoptosis response of HAM. Analysis of the THP-1 cell response to infection with virulent mycobacteria suggests that TNF death signals are blocked proximal to initiator caspase activation, at the level of TNF receptor 1 or its associated intracytoplasmic adaptor complex. Interference with TNF death signaling may be a virulence mechanism that allows M. tuberculosis to circumvent innate defenses leading to apoptosis of infected host cells.
Bai X, Gao J, Guan X, Narum D, Fornis L, Griffith D Physiol Rep. 2024; 12(14):e16124.
PMID: 39016119 PMC: 11252833. DOI: 10.14814/phy2.16124.
Selisana S, Chen X, Mahfudhoh E, Bowolaksono A, Rozaliyani A, Orihara K Med Microbiol Immunol. 2024; 213(1):13.
PMID: 38967888 PMC: 11226559. DOI: 10.1007/s00430-024-00795-y.
Yang X, Chen Y, Pu B, Yuan X, Wang J, Chen C Mol Biotechnol. 2024; 67(2):778-789.
PMID: 38492118 DOI: 10.1007/s12033-024-01093-x.
: immune response, biomarkers, and therapeutic intervention.
Zhuang L, Yang L, Li L, Ye Z, Gong W MedComm (2020). 2024; 5(1):e419.
PMID: 38188605 PMC: 10771061. DOI: 10.1002/mco2.419.
Yang L, Zhuang L, Ye Z, Li L, Guan J, Gong W iScience. 2023; 26(10):107881.
PMID: 37841590 PMC: 10570004. DOI: 10.1016/j.isci.2023.107881.